These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8216215)

  • 1. Reduction of the surface-tension-lowering ability of surfactant after exposure to hypochlorous acid.
    Merritt TA; Amirkhanian JD; Helbock H; Halliwell B; Cross CE
    Biochem J; 1993 Oct; 295 ( Pt 1)(Pt 1):19-22. PubMed ID: 8216215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants.
    Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH
    Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of bilirubin on surface tension properties of lung surfactant.
    Amato M; Schürch S; Grunder R; Bachofen H; Burri PH
    Arch Dis Child Fetal Neonatal Ed; 1996 Nov; 75(3):F191-6. PubMed ID: 8976686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of surfactant mixtures with reactive oxygen and nitrogen species.
    Cifuentes J; Ruiz-Oronoz J; Myles C; Nieves B; Carlo WA; Matalon S
    J Appl Physiol (1985); 1995 May; 78(5):1800-5. PubMed ID: 7649915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Biophysical models in investigations of exogenous surfactant activities on the surface tension and their theurapeutic effectiveness].
    Todorov R; Iordanova A; Georgiev GA; Petkova Kh; Stoimenova E; Georgieva R; Khristova E; Vasiliev Kh; Lalchev Z
    Akush Ginekol (Sofiia); 2007; 46 Suppl 1():29-36. PubMed ID: 18175392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactivation of surfactant in rat lungs.
    Bruni R; Fan BR; David-Cu R; Taeusch HW; Walther FJ
    Pediatr Res; 1996 Feb; 39(2):236-40. PubMed ID: 8825793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of surface properties and physiological effects of a synthetic and a natural surfactant in preterm rabbits.
    Corcoran JD; Berggren P; Sun B; Halliday HL; Robertson B; Curstedt T
    Arch Dis Child Fetal Neonatal Ed; 1994 Nov; 71(3):F165-9. PubMed ID: 7820710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of in vitro surface properties of clove oil-phospholipid suspensions with those of ALEC, Exosurf and Survanta.
    Banerjee R; Bellare JR
    Pulm Pharmacol Ther; 2001; 14(2):85-91. PubMed ID: 11273788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized trial comparing synthetic surfactant with modified bovine surfactant extract in the treatment of neonatal respiratory distress syndrome. Vermont-Oxford Neonatal Network.
    Pediatrics; 1996 Jan; 97(1):1-6. PubMed ID: 8545199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: a component of the synthetic surfactant Exosurf.
    Thomassen MJ; Antal JM; Divis LT; Wiedemann HP
    Clin Immunol Immunopathol; 1995 Nov; 77(2):201-5. PubMed ID: 7586728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of exogenous surfactant on the development of surfactant synthesis in premature rabbit lung.
    Amato M; Petit K; Fiore HH; Doyle CA; Frantz ID; Nielsen HC
    Pediatr Res; 2003 Apr; 53(4):671-8. PubMed ID: 12612208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of modified natural or synthetic surfactant preparations on growth of bacteria causing infections in the neonatal period.
    Rauprich P; Möller O; Walter G; Herting E; Robertson B
    Clin Diagn Lab Immunol; 2000 Sep; 7(5):817-22. PubMed ID: 10973461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
    Manalo E; Merritt TA; Kheiter A; Amirkhanian J; Cochrane C
    Pediatr Res; 1996 Jun; 39(6):947-52. PubMed ID: 8725253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bulk shear viscosities of endogenous and exogenous lung surfactants.
    King DM; Wang Z; Palmer HJ; Holm BA; Notter RH
    Am J Physiol Lung Cell Mol Physiol; 2002 Feb; 282(2):L277-84. PubMed ID: 11792632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL
    Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of pH on surface properties of lung surfactants.
    Amirkhanian JD; Merritt TA
    Lung; 1995; 173(4):243-54. PubMed ID: 7564483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of bilirubin toxicity.
    Amato M
    Eur J Pediatr; 1995; 154(9 Suppl 4):S54-9. PubMed ID: 8529712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exogenous surfactants in a piglet model of acute respiratory distress syndrome.
    Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D
    Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Susceptibility of exogenous surfactant to phospholipase A2 degradation.
    Duncan JE; Hatch GM; Belik J
    Can J Physiol Pharmacol; 1996 Aug; 74(8):957-63. PubMed ID: 8960386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surface tension of therapeutic surfactants (exosurf neonatal, infasurf, and survanta) as evaluated by standard methods and criteria.
    Scarpelli EM; David E; Cordova M; Mautone AJ
    Am J Perinatol; 1992; 9(5-6):414-9. PubMed ID: 1418146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.